Leishmania tropica major is a subspecies of L. t., distributed in desert and semi-desert regions of the Middle East, Central Asia, North and East Africa. Its reservoir is wild mammals, mainly rodents. L. tropica major is the causative agent of zoonotic cutaneous leishmaniasis. This parasitic, single-celled protozoan is transmitted to humans through the bites of infected Phlebotomus mosquitoes. Skin lesions caused by L. tropica major infection are characterized by the appearance of painful ulcers and nodules. Treatment includes the administration of antileishmanial drugs. Vector control and vaccination help prevent cases in some regions.
Leishmania Tropica Major is a subspecies of the causative agent of cutaneous leishmaniasis that is distributed in desert and semi-desert regions of the Middle East and North Africa. This infectious disease is caused by protozoa that are transmitted from wild rodents and other animals.
Leishmania Tropica Major can cause zoonotic cutaneous leishmaniasis in humans, which is characterized by skin ulcers that may be painful and bleed. Treatment of this disease includes taking antibiotics and immunomodulators.
However, although Leishmania Tropica Major is a common disease in some regions of the world, its diagnosis and treatment can be difficult due to the lack of accurate diagnostic methods and insufficient experience of doctors. Therefore, it is important to conduct regular medical examinations and consult a doctor if you suspect this disease.